nodes	percent_of_prediction	percent_of_DWPC	metapath
Pazopanib—ABCB1—ulcerative colitis	0.141	1	CbGaD
Pazopanib—SLCO1B1—Sulfasalazine—ulcerative colitis	0.0415	0.11	CbGbCtD
Pazopanib—ABCG2—Sulfasalazine—ulcerative colitis	0.033	0.0876	CbGbCtD
Pazopanib—ABCG2—Hydrocortisone—ulcerative colitis	0.0265	0.0703	CbGbCtD
Pazopanib—CYP2C8—Nicotine—ulcerative colitis	0.0226	0.06	CbGbCtD
Pazopanib—CYP3A4—Budesonide—ulcerative colitis	0.0211	0.0559	CbGbCtD
Pazopanib—CYP2C8—Cholecalciferol—ulcerative colitis	0.0203	0.0538	CbGbCtD
Pazopanib—CYP1A2—Nicotine—ulcerative colitis	0.0175	0.0464	CbGbCtD
Pazopanib—ABCG2—Dexamethasone—ulcerative colitis	0.0165	0.0437	CbGbCtD
Pazopanib—ABCB1—Methylprednisolone—ulcerative colitis	0.0157	0.0417	CbGbCtD
Pazopanib—CYP2D6—Nicotine—ulcerative colitis	0.0144	0.0383	CbGbCtD
Pazopanib—CYP2C8—Hydrocortisone—ulcerative colitis	0.0141	0.0374	CbGbCtD
Pazopanib—CYP2D6—Cholecalciferol—ulcerative colitis	0.0129	0.0343	CbGbCtD
Pazopanib—ABCB1—Betamethasone—ulcerative colitis	0.0102	0.0271	CbGbCtD
Pazopanib—ABCB1—Prednisolone—ulcerative colitis	0.0101	0.0267	CbGbCtD
Pazopanib—ABCB1—Hydrocortisone—ulcerative colitis	0.00954	0.0253	CbGbCtD
Pazopanib—ABCB1—Prednisone—ulcerative colitis	0.00951	0.0252	CbGbCtD
Pazopanib—CYP3A4—Methylprednisolone—ulcerative colitis	0.0094	0.025	CbGbCtD
Pazopanib—KIT—myenteric nerve plexus—ulcerative colitis	0.00938	0.0945	CbGeAlD
Pazopanib—CYP3A4—Nicotine—ulcerative colitis	0.00916	0.0243	CbGbCtD
Pazopanib—CYP2C8—Dexamethasone—ulcerative colitis	0.00877	0.0233	CbGbCtD
Pazopanib—CYP3A4—Cholecalciferol—ulcerative colitis	0.00822	0.0218	CbGbCtD
Pazopanib—CYP3A4—Triamcinolone—ulcerative colitis	0.00713	0.0189	CbGbCtD
Pazopanib—CYP3A4—Betamethasone—ulcerative colitis	0.00611	0.0162	CbGbCtD
Pazopanib—CYP3A4—Prednisolone—ulcerative colitis	0.00603	0.016	CbGbCtD
Pazopanib—ABCB1—Dexamethasone—ulcerative colitis	0.00594	0.0158	CbGbCtD
Pazopanib—CYP3A4—Hydrocortisone—ulcerative colitis	0.00572	0.0152	CbGbCtD
Pazopanib—CYP3A4—Prednisone—ulcerative colitis	0.0057	0.0151	CbGbCtD
Pazopanib—CYP2D6—Dexamethasone—ulcerative colitis	0.00559	0.0149	CbGbCtD
Pazopanib—CYP3A4—Dexamethasone—ulcerative colitis	0.00356	0.00944	CbGbCtD
Pazopanib—MAP3K9—epithelium—ulcerative colitis	0.00347	0.035	CbGeAlD
Pazopanib—MAP3K9—digestive system—ulcerative colitis	0.00264	0.0266	CbGeAlD
Pazopanib—ITK—lymphoid tissue—ulcerative colitis	0.00221	0.0222	CbGeAlD
Pazopanib—FGFR3—epithelium—ulcerative colitis	0.00205	0.0207	CbGeAlD
Pazopanib—BMPR1B—epithelium—ulcerative colitis	0.00203	0.0205	CbGeAlD
Pazopanib—MAP3K9—liver—ulcerative colitis	0.00197	0.0198	CbGeAlD
Pazopanib—SH2B3—lymphoid tissue—ulcerative colitis	0.00189	0.019	CbGeAlD
Pazopanib—PI4KB—smooth muscle tissue—ulcerative colitis	0.00175	0.0176	CbGeAlD
Pazopanib—PLK4—lymphoid tissue—ulcerative colitis	0.0017	0.0171	CbGeAlD
Pazopanib—STK16—lymphoid tissue—ulcerative colitis	0.00161	0.0162	CbGeAlD
Pazopanib—FLT4—epithelium—ulcerative colitis	0.0016	0.0162	CbGeAlD
Pazopanib—LYN—lymphoid tissue—ulcerative colitis	0.00159	0.016	CbGeAlD
Pazopanib—STK16—digestive system—ulcerative colitis	0.00159	0.016	CbGeAlD
Pazopanib—TAOK1—liver—ulcerative colitis	0.00148	0.0149	CbGeAlD
Pazopanib—FGF1—epithelium—ulcerative colitis	0.00142	0.0143	CbGeAlD
Pazopanib—SH2B3—liver—ulcerative colitis	0.00139	0.014	CbGeAlD
Pazopanib—LIMK2—lymphoid tissue—ulcerative colitis	0.00137	0.0138	CbGeAlD
Pazopanib—FGF1—smooth muscle tissue—ulcerative colitis	0.00137	0.0138	CbGeAlD
Pazopanib—Rilpivirine—ABCB1—ulcerative colitis	0.00136	1	CrCbGaD
Pazopanib—FGFR2—epithelium—ulcerative colitis	0.00135	0.0135	CbGeAlD
Pazopanib—FGFR2—smooth muscle tissue—ulcerative colitis	0.0013	0.0131	CbGeAlD
Pazopanib—FLT1—epithelium—ulcerative colitis	0.00125	0.0126	CbGeAlD
Pazopanib—FLT4—lymphoid tissue—ulcerative colitis	0.00124	0.0124	CbGeAlD
Pazopanib—FLT1—smooth muscle tissue—ulcerative colitis	0.0012	0.0121	CbGeAlD
Pazopanib—STK16—liver—ulcerative colitis	0.00118	0.0119	CbGeAlD
Pazopanib—LYN—liver—ulcerative colitis	0.00117	0.0118	CbGeAlD
Pazopanib—RIOK2—liver—ulcerative colitis	0.00116	0.0117	CbGeAlD
Pazopanib—FGFR3—liver—ulcerative colitis	0.00116	0.0117	CbGeAlD
Pazopanib—MAP3K2—lymphoid tissue—ulcerative colitis	0.00116	0.0117	CbGeAlD
Pazopanib—PDGFRA—smooth muscle tissue—ulcerative colitis	0.00113	0.0113	CbGeAlD
Pazopanib—FGF1—lymphoid tissue—ulcerative colitis	0.0011	0.0111	CbGeAlD
Pazopanib—FGF1—digestive system—ulcerative colitis	0.00108	0.0109	CbGeAlD
Pazopanib—KDR—epithelium—ulcerative colitis	0.00105	0.0106	CbGeAlD
Pazopanib—STK36—liver—ulcerative colitis	0.00105	0.0105	CbGeAlD
Pazopanib—PI4KB—liver—ulcerative colitis	0.00103	0.0104	CbGeAlD
Pazopanib—FGFR2—digestive system—ulcerative colitis	0.00102	0.0103	CbGeAlD
Pazopanib—KDR—smooth muscle tissue—ulcerative colitis	0.00102	0.0102	CbGeAlD
Pazopanib—LIMK2—liver—ulcerative colitis	0.00101	0.0102	CbGeAlD
Pazopanib—CSF1R—smooth muscle tissue—ulcerative colitis	0.000991	0.00998	CbGeAlD
Pazopanib—FLT1—lymphoid tissue—ulcerative colitis	0.00096	0.00967	CbGeAlD
Pazopanib—FLT1—digestive system—ulcerative colitis	0.000949	0.00955	CbGeAlD
Pazopanib—KIT—epithelium—ulcerative colitis	0.000934	0.00941	CbGeAlD
Pazopanib—PDGFRB—epithelium—ulcerative colitis	0.000912	0.00919	CbGeAlD
Pazopanib—STK10—lymphoid tissue—ulcerative colitis	0.000909	0.00916	CbGeAlD
Pazopanib—FLT4—liver—ulcerative colitis	0.000909	0.00915	CbGeAlD
Pazopanib—TAOK3—lymphoid tissue—ulcerative colitis	0.000906	0.00912	CbGeAlD
Pazopanib—PIP4K2C—liver—ulcerative colitis	0.000904	0.0091	CbGeAlD
Pazopanib—KIT—smooth muscle tissue—ulcerative colitis	0.0009	0.00907	CbGeAlD
Pazopanib—PDGFRA—lymphoid tissue—ulcerative colitis	0.0009	0.00906	CbGeAlD
Pazopanib—STK10—digestive system—ulcerative colitis	0.000898	0.00904	CbGeAlD
Pazopanib—FGFR1—liver—ulcerative colitis	0.000897	0.00903	CbGeAlD
Pazopanib—TAOK3—digestive system—ulcerative colitis	0.000894	0.00901	CbGeAlD
Pazopanib—PDGFRA—digestive system—ulcerative colitis	0.000889	0.00895	CbGeAlD
Pazopanib—PDGFRB—smooth muscle tissue—ulcerative colitis	0.000879	0.00885	CbGeAlD
Pazopanib—MAP3K2—liver—ulcerative colitis	0.000857	0.00863	CbGeAlD
Pazopanib—UGT1A1—digestive system—ulcerative colitis	0.000848	0.00854	CbGeAlD
Pazopanib—KDR—lymphoid tissue—ulcerative colitis	0.000812	0.00818	CbGeAlD
Pazopanib—FGF1—liver—ulcerative colitis	0.000807	0.00813	CbGeAlD
Pazopanib—LCK—liver—ulcerative colitis	0.000802	0.00808	CbGeAlD
Pazopanib—KDR—digestive system—ulcerative colitis	0.000802	0.00808	CbGeAlD
Pazopanib—CSF1R—lymphoid tissue—ulcerative colitis	0.000792	0.00798	CbGeAlD
Pazopanib—CSF1R—digestive system—ulcerative colitis	0.000783	0.00788	CbGeAlD
Pazopanib—FGFR2—liver—ulcerative colitis	0.000762	0.00768	CbGeAlD
Pazopanib—KIT—lymphoid tissue—ulcerative colitis	0.000719	0.00725	CbGeAlD
Pazopanib—KIT—digestive system—ulcerative colitis	0.000711	0.00716	CbGeAlD
Pazopanib—FLT1—liver—ulcerative colitis	0.000707	0.00712	CbGeAlD
Pazopanib—SLCO1B1—digestive system—ulcerative colitis	0.000706	0.00711	CbGeAlD
Pazopanib—PDGFRB—lymphoid tissue—ulcerative colitis	0.000703	0.00708	CbGeAlD
Pazopanib—PDGFRB—digestive system—ulcerative colitis	0.000694	0.00699	CbGeAlD
Pazopanib—STK10—liver—ulcerative colitis	0.000669	0.00674	CbGeAlD
Pazopanib—TAOK3—liver—ulcerative colitis	0.000666	0.00671	CbGeAlD
Pazopanib—PDGFRA—liver—ulcerative colitis	0.000662	0.00667	CbGeAlD
Pazopanib—UGT1A1—liver—ulcerative colitis	0.000632	0.00636	CbGeAlD
Pazopanib—SH2B3—Dexamethasone—Budesonide—ulcerative colitis	0.0006	0.131	CbGdCrCtD
Pazopanib—SH2B3—Betamethasone—Budesonide—ulcerative colitis	0.0006	0.131	CbGdCrCtD
Pazopanib—KDR—liver—ulcerative colitis	0.000597	0.00602	CbGeAlD
Pazopanib—MAP2K5—liver—ulcerative colitis	0.000597	0.00602	CbGeAlD
Pazopanib—CSF1R—liver—ulcerative colitis	0.000583	0.00587	CbGeAlD
Pazopanib—KIT—liver—ulcerative colitis	0.000529	0.00533	CbGeAlD
Pazopanib—SLCO1B1—liver—ulcerative colitis	0.000526	0.00529	CbGeAlD
Pazopanib—PDGFRB—liver—ulcerative colitis	0.000517	0.00521	CbGeAlD
Pazopanib—CYP1A2—digestive system—ulcerative colitis	0.000375	0.00378	CbGeAlD
Pazopanib—SH2B3—Betamethasone—Hydrocortisone—ulcerative colitis	0.000307	0.0672	CbGdCrCtD
Pazopanib—SH2B3—Dexamethasone—Hydrocortisone—ulcerative colitis	0.000307	0.0672	CbGdCrCtD
Pazopanib—CYP2C8—liver—ulcerative colitis	0.000299	0.00301	CbGeAlD
Pazopanib—ABCG2—liver—ulcerative colitis	0.000291	0.00293	CbGeAlD
Pazopanib—SH2B3—Dexamethasone—Methylprednisolone—ulcerative colitis	0.00029	0.0635	CbGdCrCtD
Pazopanib—SH2B3—Betamethasone—Methylprednisolone—ulcerative colitis	0.00029	0.0635	CbGdCrCtD
Pazopanib—SH2B3—Dexamethasone—Betamethasone—ulcerative colitis	0.000285	0.0625	CbGdCrCtD
Pazopanib—SH2B3—Betamethasone—Dexamethasone—ulcerative colitis	0.000285	0.0625	CbGdCrCtD
Pazopanib—CYP1A2—liver—ulcerative colitis	0.00028	0.00282	CbGeAlD
Pazopanib—SH2B3—Dexamethasone—Triamcinolone—ulcerative colitis	0.000279	0.061	CbGdCrCtD
Pazopanib—SH2B3—Betamethasone—Triamcinolone—ulcerative colitis	0.000279	0.061	CbGdCrCtD
Pazopanib—CYP3A4—digestive system—ulcerative colitis	0.000272	0.00274	CbGeAlD
Pazopanib—CYP2D6—digestive system—ulcerative colitis	0.000267	0.00269	CbGeAlD
Pazopanib—SH2B3—Dexamethasone—Prednisone—ulcerative colitis	0.000265	0.0579	CbGdCrCtD
Pazopanib—SH2B3—Betamethasone—Prednisone—ulcerative colitis	0.000265	0.0579	CbGdCrCtD
Pazopanib—SH2B3—Dexamethasone—Prednisolone—ulcerative colitis	0.000258	0.0565	CbGdCrCtD
Pazopanib—SH2B3—Betamethasone—Prednisolone—ulcerative colitis	0.000258	0.0565	CbGdCrCtD
Pazopanib—ABCB1—epithelium—ulcerative colitis	0.000253	0.00255	CbGeAlD
Pazopanib—CYP3A4—liver—ulcerative colitis	0.000202	0.00204	CbGeAlD
Pazopanib—CYP2D6—liver—ulcerative colitis	0.000199	0.00201	CbGeAlD
Pazopanib—ABCB1—lymphoid tissue—ulcerative colitis	0.000195	0.00196	CbGeAlD
Pazopanib—ABCB1—digestive system—ulcerative colitis	0.000192	0.00194	CbGeAlD
Pazopanib—Fatigue—Mesalazine—ulcerative colitis	0.000145	0.000792	CcSEcCtD
Pazopanib—Haemoglobin—Betamethasone—ulcerative colitis	0.000145	0.00079	CcSEcCtD
Pazopanib—Haemoglobin—Dexamethasone—ulcerative colitis	0.000145	0.00079	CcSEcCtD
Pazopanib—Pain—Mesalazine—ulcerative colitis	0.000144	0.000786	CcSEcCtD
Pazopanib—Haemorrhage—Betamethasone—ulcerative colitis	0.000144	0.000786	CcSEcCtD
Pazopanib—Haemorrhage—Dexamethasone—ulcerative colitis	0.000144	0.000786	CcSEcCtD
Pazopanib—Angiopathy—Methylprednisolone—ulcerative colitis	0.000144	0.000784	CcSEcCtD
Pazopanib—ABCB1—liver—ulcerative colitis	0.000143	0.00144	CbGeAlD
Pazopanib—Mediastinal disorder—Methylprednisolone—ulcerative colitis	0.000143	0.000779	CcSEcCtD
Pazopanib—Weight decreased—Prednisone—ulcerative colitis	0.000142	0.000774	CcSEcCtD
Pazopanib—Diarrhoea—Budesonide—ulcerative colitis	0.000142	0.000773	CcSEcCtD
Pazopanib—Vision blurred—Prednisolone—ulcerative colitis	0.000141	0.000773	CcSEcCtD
Pazopanib—Mental disorder—Methylprednisolone—ulcerative colitis	0.000139	0.000757	CcSEcCtD
Pazopanib—Erythema—Triamcinolone—ulcerative colitis	0.000138	0.000754	CcSEcCtD
Pazopanib—Erythema—Methylprednisolone—ulcerative colitis	0.000138	0.000752	CcSEcCtD
Pazopanib—Malnutrition—Methylprednisolone—ulcerative colitis	0.000138	0.000752	CcSEcCtD
Pazopanib—Acute coronary syndrome—Prednisone—ulcerative colitis	0.000138	0.000752	CcSEcCtD
Pazopanib—Gastrointestinal pain—Mesalazine—ulcerative colitis	0.000138	0.000751	CcSEcCtD
Pazopanib—Myocardial infarction—Prednisone—ulcerative colitis	0.000137	0.000747	CcSEcCtD
Pazopanib—Dizziness—Budesonide—ulcerative colitis	0.000137	0.000747	CcSEcCtD
Pazopanib—Dysgeusia—Triamcinolone—ulcerative colitis	0.000135	0.000738	CcSEcCtD
Pazopanib—Syncope—Prednisolone—ulcerative colitis	0.000135	0.000735	CcSEcCtD
Pazopanib—Eye disorder—Dexamethasone—ulcerative colitis	0.000134	0.000734	CcSEcCtD
Pazopanib—Eye disorder—Betamethasone—ulcerative colitis	0.000134	0.000734	CcSEcCtD
Pazopanib—Abdominal pain—Mesalazine—ulcerative colitis	0.000133	0.000726	CcSEcCtD
Pazopanib—Loss of consciousness—Prednisolone—ulcerative colitis	0.000132	0.000721	CcSEcCtD
Pazopanib—Vomiting—Budesonide—ulcerative colitis	0.000132	0.000718	CcSEcCtD
Pazopanib—Syncope—Hydrocortisone—ulcerative colitis	0.000131	0.000718	CcSEcCtD
Pazopanib—Angiopathy—Betamethasone—ulcerative colitis	0.000131	0.000713	CcSEcCtD
Pazopanib—Angiopathy—Dexamethasone—ulcerative colitis	0.000131	0.000713	CcSEcCtD
Pazopanib—Rash—Budesonide—ulcerative colitis	0.00013	0.000712	CcSEcCtD
Pazopanib—Dermatitis—Budesonide—ulcerative colitis	0.00013	0.000712	CcSEcCtD
Pazopanib—Headache—Budesonide—ulcerative colitis	0.00013	0.000708	CcSEcCtD
Pazopanib—Hypertension—Prednisolone—ulcerative colitis	0.00013	0.000708	CcSEcCtD
Pazopanib—Loss of consciousness—Hydrocortisone—ulcerative colitis	0.000129	0.000704	CcSEcCtD
Pazopanib—Bradycardia—Prednisone—ulcerative colitis	0.000128	0.000697	CcSEcCtD
Pazopanib—Alopecia—Betamethasone—ulcerative colitis	0.000127	0.000694	CcSEcCtD
Pazopanib—Alopecia—Dexamethasone—ulcerative colitis	0.000127	0.000694	CcSEcCtD
Pazopanib—Hypertension—Hydrocortisone—ulcerative colitis	0.000127	0.000691	CcSEcCtD
Pazopanib—Diarrhoea—Azathioprine—ulcerative colitis	0.000126	0.00069	CcSEcCtD
Pazopanib—Haemoglobin—Prednisone—ulcerative colitis	0.000126	0.000688	CcSEcCtD
Pazopanib—Haemorrhage—Prednisone—ulcerative colitis	0.000125	0.000684	CcSEcCtD
Pazopanib—Erythema—Dexamethasone—ulcerative colitis	0.000125	0.000684	CcSEcCtD
Pazopanib—Erythema—Betamethasone—ulcerative colitis	0.000125	0.000684	CcSEcCtD
Pazopanib—Myalgia—Hydrocortisone—ulcerative colitis	0.000125	0.000682	CcSEcCtD
Pazopanib—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—ulcerative colitis	0.000124	0.000677	CcSEcCtD
Pazopanib—Syncope—Triamcinolone—ulcerative colitis	0.000124	0.000676	CcSEcCtD
Pazopanib—Syncope—Methylprednisolone—ulcerative colitis	0.000124	0.000675	CcSEcCtD
Pazopanib—Connective tissue disorder—Prednisone—ulcerative colitis	0.000123	0.000673	CcSEcCtD
Pazopanib—Nausea—Budesonide—ulcerative colitis	0.000123	0.000671	CcSEcCtD
Pazopanib—Oedema—Prednisolone—ulcerative colitis	0.000123	0.000669	CcSEcCtD
Pazopanib—Dizziness—Azathioprine—ulcerative colitis	0.000122	0.000667	CcSEcCtD
Pazopanib—Loss of consciousness—Triamcinolone—ulcerative colitis	0.000121	0.000663	CcSEcCtD
Pazopanib—Loss of consciousness—Methylprednisolone—ulcerative colitis	0.000121	0.000661	CcSEcCtD
Pazopanib—Asthenia—Mesalazine—ulcerative colitis	0.000121	0.000659	CcSEcCtD
Pazopanib—Shock—Prednisolone—ulcerative colitis	0.000121	0.000658	CcSEcCtD
Pazopanib—Cough—Triamcinolone—ulcerative colitis	0.00012	0.000658	CcSEcCtD
Pazopanib—Oedema—Hydrocortisone—ulcerative colitis	0.00012	0.000653	CcSEcCtD
Pazopanib—Hypertension—Triamcinolone—ulcerative colitis	0.000119	0.000651	CcSEcCtD
Pazopanib—Pruritus—Mesalazine—ulcerative colitis	0.000119	0.00065	CcSEcCtD
Pazopanib—Hypertension—Methylprednisolone—ulcerative colitis	0.000119	0.000649	CcSEcCtD
Pazopanib—Infection—Hydrocortisone—ulcerative colitis	0.000119	0.000649	CcSEcCtD
Pazopanib—Hyperhidrosis—Prednisolone—ulcerative colitis	0.000118	0.000647	CcSEcCtD
Pazopanib—Shock—Hydrocortisone—ulcerative colitis	0.000118	0.000643	CcSEcCtD
Pazopanib—Myalgia—Triamcinolone—ulcerative colitis	0.000118	0.000642	CcSEcCtD
Pazopanib—Vomiting—Azathioprine—ulcerative colitis	0.000117	0.000641	CcSEcCtD
Pazopanib—Nervous system disorder—Hydrocortisone—ulcerative colitis	0.000117	0.000641	CcSEcCtD
Pazopanib—Myalgia—Methylprednisolone—ulcerative colitis	0.000117	0.00064	CcSEcCtD
Pazopanib—Arthralgia—Methylprednisolone—ulcerative colitis	0.000117	0.00064	CcSEcCtD
Pazopanib—Eye disorder—Prednisone—ulcerative colitis	0.000117	0.00064	CcSEcCtD
Pazopanib—Rash—Azathioprine—ulcerative colitis	0.000116	0.000636	CcSEcCtD
Pazopanib—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ulcerative colitis	0.000116	0.000636	CcSEcCtD
Pazopanib—Dermatitis—Azathioprine—ulcerative colitis	0.000116	0.000636	CcSEcCtD
Pazopanib—Flushing—Prednisone—ulcerative colitis	0.000116	0.000635	CcSEcCtD
Pazopanib—Skin disorder—Hydrocortisone—ulcerative colitis	0.000116	0.000635	CcSEcCtD
Pazopanib—Headache—Azathioprine—ulcerative colitis	0.000116	0.000632	CcSEcCtD
Pazopanib—Hyperhidrosis—Hydrocortisone—ulcerative colitis	0.000116	0.000632	CcSEcCtD
Pazopanib—Diarrhoea—Mesalazine—ulcerative colitis	0.000115	0.000629	CcSEcCtD
Pazopanib—Dry mouth—Triamcinolone—ulcerative colitis	0.000115	0.000628	CcSEcCtD
Pazopanib—Anorexia—Hydrocortisone—ulcerative colitis	0.000114	0.000623	CcSEcCtD
Pazopanib—Angiopathy—Prednisone—ulcerative colitis	0.000114	0.000621	CcSEcCtD
Pazopanib—Oedema—Triamcinolone—ulcerative colitis	0.000113	0.000615	CcSEcCtD
Pazopanib—Syncope—Betamethasone—ulcerative colitis	0.000112	0.000613	CcSEcCtD
Pazopanib—Syncope—Dexamethasone—ulcerative colitis	0.000112	0.000613	CcSEcCtD
Pazopanib—Infection—Triamcinolone—ulcerative colitis	0.000112	0.000611	CcSEcCtD
Pazopanib—Infection—Methylprednisolone—ulcerative colitis	0.000112	0.00061	CcSEcCtD
Pazopanib—Dizziness—Mesalazine—ulcerative colitis	0.000111	0.000608	CcSEcCtD
Pazopanib—Shock—Triamcinolone—ulcerative colitis	0.000111	0.000605	CcSEcCtD
Pazopanib—Insomnia—Prednisolone—ulcerative colitis	0.000111	0.000605	CcSEcCtD
Pazopanib—Alopecia—Prednisone—ulcerative colitis	0.000111	0.000605	CcSEcCtD
Pazopanib—Shock—Methylprednisolone—ulcerative colitis	0.000111	0.000604	CcSEcCtD
Pazopanib—Nervous system disorder—Methylprednisolone—ulcerative colitis	0.00011	0.000602	CcSEcCtD
Pazopanib—Loss of consciousness—Dexamethasone—ulcerative colitis	0.00011	0.000601	CcSEcCtD
Pazopanib—Loss of consciousness—Betamethasone—ulcerative colitis	0.00011	0.000601	CcSEcCtD
Pazopanib—Paraesthesia—Prednisolone—ulcerative colitis	0.00011	0.000601	CcSEcCtD
Pazopanib—Mental disorder—Prednisone—ulcerative colitis	0.00011	0.0006	CcSEcCtD
Pazopanib—Nausea—Azathioprine—ulcerative colitis	0.00011	0.000599	CcSEcCtD
Pazopanib—Skin disorder—Methylprednisolone—ulcerative colitis	0.000109	0.000596	CcSEcCtD
Pazopanib—Erythema—Prednisone—ulcerative colitis	0.000109	0.000596	CcSEcCtD
Pazopanib—Malnutrition—Prednisone—ulcerative colitis	0.000109	0.000596	CcSEcCtD
Pazopanib—Musculoskeletal discomfort—Hydrocortisone—ulcerative colitis	0.000109	0.000595	CcSEcCtD
Pazopanib—Hyperhidrosis—Triamcinolone—ulcerative colitis	0.000109	0.000595	CcSEcCtD
Pazopanib—Hyperhidrosis—Methylprednisolone—ulcerative colitis	0.000109	0.000594	CcSEcCtD
Pazopanib—Insomnia—Hydrocortisone—ulcerative colitis	0.000108	0.000591	CcSEcCtD
Pazopanib—Hypertension—Dexamethasone—ulcerative colitis	0.000108	0.000591	CcSEcCtD
Pazopanib—Hypertension—Betamethasone—ulcerative colitis	0.000108	0.000591	CcSEcCtD
Pazopanib—Paraesthesia—Hydrocortisone—ulcerative colitis	0.000107	0.000587	CcSEcCtD
Pazopanib—Vomiting—Mesalazine—ulcerative colitis	0.000107	0.000584	CcSEcCtD
Pazopanib—Myalgia—Betamethasone—ulcerative colitis	0.000107	0.000582	CcSEcCtD
Pazopanib—Myalgia—Dexamethasone—ulcerative colitis	0.000107	0.000582	CcSEcCtD
Pazopanib—Rash—Mesalazine—ulcerative colitis	0.000106	0.000579	CcSEcCtD
Pazopanib—Dermatitis—Mesalazine—ulcerative colitis	0.000106	0.000579	CcSEcCtD
Pazopanib—Headache—Mesalazine—ulcerative colitis	0.000105	0.000576	CcSEcCtD
Pazopanib—Dyspepsia—Hydrocortisone—ulcerative colitis	0.000105	0.000575	CcSEcCtD
Pazopanib—Pain—Prednisolone—ulcerative colitis	0.000105	0.000572	CcSEcCtD
Pazopanib—Decreased appetite—Hydrocortisone—ulcerative colitis	0.000104	0.000568	CcSEcCtD
Pazopanib—Gastrointestinal disorder—Hydrocortisone—ulcerative colitis	0.000103	0.000564	CcSEcCtD
Pazopanib—Fatigue—Hydrocortisone—ulcerative colitis	0.000103	0.000563	CcSEcCtD
Pazopanib—Vision blurred—Prednisone—ulcerative colitis	0.000103	0.000561	CcSEcCtD
Pazopanib—Musculoskeletal discomfort—Triamcinolone—ulcerative colitis	0.000103	0.000561	CcSEcCtD
Pazopanib—Musculoskeletal discomfort—Methylprednisolone—ulcerative colitis	0.000102	0.000559	CcSEcCtD
Pazopanib—Pain—Hydrocortisone—ulcerative colitis	0.000102	0.000559	CcSEcCtD
Pazopanib—Oedema—Dexamethasone—ulcerative colitis	0.000102	0.000558	CcSEcCtD
Pazopanib—Oedema—Betamethasone—ulcerative colitis	0.000102	0.000558	CcSEcCtD
Pazopanib—Insomnia—Triamcinolone—ulcerative colitis	0.000102	0.000557	CcSEcCtD
Pazopanib—Insomnia—Methylprednisolone—ulcerative colitis	0.000102	0.000555	CcSEcCtD
Pazopanib—Infection—Dexamethasone—ulcerative colitis	0.000102	0.000555	CcSEcCtD
Pazopanib—Infection—Betamethasone—ulcerative colitis	0.000102	0.000555	CcSEcCtD
Pazopanib—Paraesthesia—Triamcinolone—ulcerative colitis	0.000101	0.000553	CcSEcCtD
Pazopanib—Paraesthesia—Methylprednisolone—ulcerative colitis	0.000101	0.000551	CcSEcCtD
Pazopanib—Anaemia—Prednisone—ulcerative colitis	0.000101	0.000551	CcSEcCtD
Pazopanib—Shock—Betamethasone—ulcerative colitis	0.000101	0.000549	CcSEcCtD
Pazopanib—Shock—Dexamethasone—ulcerative colitis	0.000101	0.000549	CcSEcCtD
Pazopanib—Dyspnoea—Triamcinolone—ulcerative colitis	0.0001	0.000549	CcSEcCtD
Pazopanib—Nervous system disorder—Betamethasone—ulcerative colitis	0.0001	0.000548	CcSEcCtD
Pazopanib—Nervous system disorder—Dexamethasone—ulcerative colitis	0.0001	0.000548	CcSEcCtD
Pazopanib—Thrombocytopenia—Betamethasone—ulcerative colitis	0.0001	0.000547	CcSEcCtD
Pazopanib—Thrombocytopenia—Dexamethasone—ulcerative colitis	0.0001	0.000547	CcSEcCtD
Pazopanib—Nausea—Mesalazine—ulcerative colitis	0.0001	0.000546	CcSEcCtD
Pazopanib—Dyspepsia—Triamcinolone—ulcerative colitis	9.92e-05	0.000542	CcSEcCtD
Pazopanib—Dyspepsia—Methylprednisolone—ulcerative colitis	9.9e-05	0.00054	CcSEcCtD
Pazopanib—Hyperhidrosis—Betamethasone—ulcerative colitis	9.88e-05	0.00054	CcSEcCtD
Pazopanib—Hyperhidrosis—Dexamethasone—ulcerative colitis	9.88e-05	0.00054	CcSEcCtD
Pazopanib—Gastrointestinal pain—Hydrocortisone—ulcerative colitis	9.79e-05	0.000534	CcSEcCtD
Pazopanib—Syncope—Prednisone—ulcerative colitis	9.78e-05	0.000534	CcSEcCtD
Pazopanib—Anorexia—Dexamethasone—ulcerative colitis	9.75e-05	0.000532	CcSEcCtD
Pazopanib—Anorexia—Betamethasone—ulcerative colitis	9.75e-05	0.000532	CcSEcCtD
Pazopanib—Fatigue—Triamcinolone—ulcerative colitis	9.71e-05	0.000531	CcSEcCtD
Pazopanib—Fatigue—Methylprednisolone—ulcerative colitis	9.69e-05	0.000529	CcSEcCtD
Pazopanib—Pain—Triamcinolone—ulcerative colitis	9.64e-05	0.000526	CcSEcCtD
Pazopanib—Loss of consciousness—Prednisone—ulcerative colitis	9.59e-05	0.000524	CcSEcCtD
Pazopanib—Abdominal pain—Hydrocortisone—ulcerative colitis	9.46e-05	0.000517	CcSEcCtD
Pazopanib—Hypertension—Prednisone—ulcerative colitis	9.42e-05	0.000514	CcSEcCtD
Pazopanib—Musculoskeletal discomfort—Dexamethasone—ulcerative colitis	9.31e-05	0.000509	CcSEcCtD
Pazopanib—Musculoskeletal discomfort—Betamethasone—ulcerative colitis	9.31e-05	0.000509	CcSEcCtD
Pazopanib—Arthralgia—Prednisone—ulcerative colitis	9.29e-05	0.000507	CcSEcCtD
Pazopanib—Myalgia—Prednisone—ulcerative colitis	9.29e-05	0.000507	CcSEcCtD
Pazopanib—Insomnia—Betamethasone—ulcerative colitis	9.25e-05	0.000505	CcSEcCtD
Pazopanib—Insomnia—Dexamethasone—ulcerative colitis	9.25e-05	0.000505	CcSEcCtD
Pazopanib—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ulcerative colitis	9.22e-05	0.000504	CcSEcCtD
Pazopanib—Gastrointestinal pain—Methylprednisolone—ulcerative colitis	9.19e-05	0.000502	CcSEcCtD
Pazopanib—Paraesthesia—Betamethasone—ulcerative colitis	9.18e-05	0.000501	CcSEcCtD
Pazopanib—Paraesthesia—Dexamethasone—ulcerative colitis	9.18e-05	0.000501	CcSEcCtD
Pazopanib—Dyspepsia—Betamethasone—ulcerative colitis	9e-05	0.000491	CcSEcCtD
Pazopanib—Dyspepsia—Dexamethasone—ulcerative colitis	9e-05	0.000491	CcSEcCtD
Pazopanib—Oedema—Prednisone—ulcerative colitis	8.9e-05	0.000486	CcSEcCtD
Pazopanib—Abdominal pain—Methylprednisolone—ulcerative colitis	8.89e-05	0.000485	CcSEcCtD
Pazopanib—Decreased appetite—Dexamethasone—ulcerative colitis	8.89e-05	0.000485	CcSEcCtD
Pazopanib—Decreased appetite—Betamethasone—ulcerative colitis	8.89e-05	0.000485	CcSEcCtD
Pazopanib—Infection—Prednisone—ulcerative colitis	8.85e-05	0.000483	CcSEcCtD
Pazopanib—Gastrointestinal disorder—Dexamethasone—ulcerative colitis	8.83e-05	0.000482	CcSEcCtD
Pazopanib—Gastrointestinal disorder—Betamethasone—ulcerative colitis	8.83e-05	0.000482	CcSEcCtD
Pazopanib—Fatigue—Dexamethasone—ulcerative colitis	8.81e-05	0.000481	CcSEcCtD
Pazopanib—Fatigue—Betamethasone—ulcerative colitis	8.81e-05	0.000481	CcSEcCtD
Pazopanib—Shock—Prednisone—ulcerative colitis	8.76e-05	0.000478	CcSEcCtD
Pazopanib—Pain—Dexamethasone—ulcerative colitis	8.74e-05	0.000477	CcSEcCtD
Pazopanib—Pain—Betamethasone—ulcerative colitis	8.74e-05	0.000477	CcSEcCtD
Pazopanib—Nervous system disorder—Prednisone—ulcerative colitis	8.73e-05	0.000477	CcSEcCtD
Pazopanib—Skin disorder—Prednisone—ulcerative colitis	8.65e-05	0.000472	CcSEcCtD
Pazopanib—Hyperhidrosis—Prednisone—ulcerative colitis	8.61e-05	0.00047	CcSEcCtD
Pazopanib—Asthenia—Hydrocortisone—ulcerative colitis	8.59e-05	0.000469	CcSEcCtD
Pazopanib—Anorexia—Prednisone—ulcerative colitis	8.49e-05	0.000463	CcSEcCtD
Pazopanib—Pruritus—Hydrocortisone—ulcerative colitis	8.47e-05	0.000462	CcSEcCtD
Pazopanib—Gastrointestinal pain—Dexamethasone—ulcerative colitis	8.36e-05	0.000457	CcSEcCtD
Pazopanib—Gastrointestinal pain—Betamethasone—ulcerative colitis	8.36e-05	0.000457	CcSEcCtD
Pazopanib—Diarrhoea—Hydrocortisone—ulcerative colitis	8.19e-05	0.000447	CcSEcCtD
Pazopanib—Musculoskeletal discomfort—Prednisone—ulcerative colitis	8.11e-05	0.000443	CcSEcCtD
Pazopanib—Dizziness—Prednisolone—ulcerative colitis	8.1e-05	0.000442	CcSEcCtD
Pazopanib—Asthenia—Triamcinolone—ulcerative colitis	8.08e-05	0.000441	CcSEcCtD
Pazopanib—Abdominal pain—Dexamethasone—ulcerative colitis	8.08e-05	0.000441	CcSEcCtD
Pazopanib—Abdominal pain—Betamethasone—ulcerative colitis	8.08e-05	0.000441	CcSEcCtD
Pazopanib—Asthenia—Methylprednisolone—ulcerative colitis	8.07e-05	0.00044	CcSEcCtD
Pazopanib—Insomnia—Prednisone—ulcerative colitis	8.05e-05	0.00044	CcSEcCtD
Pazopanib—Paraesthesia—Prednisone—ulcerative colitis	7.99e-05	0.000437	CcSEcCtD
Pazopanib—Pruritus—Triamcinolone—ulcerative colitis	7.97e-05	0.000435	CcSEcCtD
Pazopanib—Pruritus—Methylprednisolone—ulcerative colitis	7.95e-05	0.000434	CcSEcCtD
Pazopanib—Dizziness—Hydrocortisone—ulcerative colitis	7.91e-05	0.000432	CcSEcCtD
Pazopanib—Dyspepsia—Prednisone—ulcerative colitis	7.84e-05	0.000428	CcSEcCtD
Pazopanib—Decreased appetite—Prednisone—ulcerative colitis	7.74e-05	0.000423	CcSEcCtD
Pazopanib—Rash—Prednisolone—ulcerative colitis	7.73e-05	0.000422	CcSEcCtD
Pazopanib—Dermatitis—Prednisolone—ulcerative colitis	7.72e-05	0.000421	CcSEcCtD
Pazopanib—Diarrhoea—Methylprednisolone—ulcerative colitis	7.69e-05	0.00042	CcSEcCtD
Pazopanib—Fatigue—Prednisone—ulcerative colitis	7.68e-05	0.000419	CcSEcCtD
Pazopanib—Headache—Prednisolone—ulcerative colitis	7.68e-05	0.000419	CcSEcCtD
Pazopanib—Vomiting—Hydrocortisone—ulcerative colitis	7.61e-05	0.000415	CcSEcCtD
Pazopanib—Rash—Hydrocortisone—ulcerative colitis	7.54e-05	0.000412	CcSEcCtD
Pazopanib—Dermatitis—Hydrocortisone—ulcerative colitis	7.54e-05	0.000412	CcSEcCtD
Pazopanib—Headache—Hydrocortisone—ulcerative colitis	7.5e-05	0.000409	CcSEcCtD
Pazopanib—Dizziness—Triamcinolone—ulcerative colitis	7.45e-05	0.000407	CcSEcCtD
Pazopanib—Dizziness—Methylprednisolone—ulcerative colitis	7.43e-05	0.000406	CcSEcCtD
Pazopanib—Asthenia—Betamethasone—ulcerative colitis	7.34e-05	0.000401	CcSEcCtD
Pazopanib—Asthenia—Dexamethasone—ulcerative colitis	7.34e-05	0.000401	CcSEcCtD
Pazopanib—Gastrointestinal pain—Prednisone—ulcerative colitis	7.28e-05	0.000398	CcSEcCtD
Pazopanib—Nausea—Prednisolone—ulcerative colitis	7.28e-05	0.000397	CcSEcCtD
Pazopanib—Pruritus—Dexamethasone—ulcerative colitis	7.23e-05	0.000395	CcSEcCtD
Pazopanib—Pruritus—Betamethasone—ulcerative colitis	7.23e-05	0.000395	CcSEcCtD
Pazopanib—Vomiting—Triamcinolone—ulcerative colitis	7.16e-05	0.000391	CcSEcCtD
Pazopanib—Vomiting—Methylprednisolone—ulcerative colitis	7.15e-05	0.00039	CcSEcCtD
Pazopanib—Nausea—Hydrocortisone—ulcerative colitis	7.11e-05	0.000388	CcSEcCtD
Pazopanib—Rash—Triamcinolone—ulcerative colitis	7.1e-05	0.000388	CcSEcCtD
Pazopanib—Dermatitis—Triamcinolone—ulcerative colitis	7.1e-05	0.000388	CcSEcCtD
Pazopanib—Rash—Methylprednisolone—ulcerative colitis	7.09e-05	0.000387	CcSEcCtD
Pazopanib—Dermatitis—Methylprednisolone—ulcerative colitis	7.08e-05	0.000387	CcSEcCtD
Pazopanib—Headache—Triamcinolone—ulcerative colitis	7.06e-05	0.000385	CcSEcCtD
Pazopanib—Headache—Methylprednisolone—ulcerative colitis	7.04e-05	0.000385	CcSEcCtD
Pazopanib—Abdominal pain—Prednisone—ulcerative colitis	7.04e-05	0.000384	CcSEcCtD
Pazopanib—Diarrhoea—Dexamethasone—ulcerative colitis	7e-05	0.000382	CcSEcCtD
Pazopanib—Diarrhoea—Betamethasone—ulcerative colitis	7e-05	0.000382	CcSEcCtD
Pazopanib—Dizziness—Betamethasone—ulcerative colitis	6.76e-05	0.000369	CcSEcCtD
Pazopanib—Dizziness—Dexamethasone—ulcerative colitis	6.76e-05	0.000369	CcSEcCtD
Pazopanib—Nausea—Triamcinolone—ulcerative colitis	6.69e-05	0.000365	CcSEcCtD
Pazopanib—Nausea—Methylprednisolone—ulcerative colitis	6.68e-05	0.000365	CcSEcCtD
Pazopanib—Vomiting—Betamethasone—ulcerative colitis	6.5e-05	0.000355	CcSEcCtD
Pazopanib—Vomiting—Dexamethasone—ulcerative colitis	6.5e-05	0.000355	CcSEcCtD
Pazopanib—Rash—Dexamethasone—ulcerative colitis	6.45e-05	0.000352	CcSEcCtD
Pazopanib—Rash—Betamethasone—ulcerative colitis	6.45e-05	0.000352	CcSEcCtD
Pazopanib—Dermatitis—Dexamethasone—ulcerative colitis	6.44e-05	0.000352	CcSEcCtD
Pazopanib—Dermatitis—Betamethasone—ulcerative colitis	6.44e-05	0.000352	CcSEcCtD
Pazopanib—Headache—Dexamethasone—ulcerative colitis	6.4e-05	0.00035	CcSEcCtD
Pazopanib—Headache—Betamethasone—ulcerative colitis	6.4e-05	0.00035	CcSEcCtD
Pazopanib—Asthenia—Prednisone—ulcerative colitis	6.39e-05	0.000349	CcSEcCtD
Pazopanib—Pruritus—Prednisone—ulcerative colitis	6.3e-05	0.000344	CcSEcCtD
Pazopanib—Diarrhoea—Prednisone—ulcerative colitis	6.09e-05	0.000333	CcSEcCtD
Pazopanib—Nausea—Dexamethasone—ulcerative colitis	6.07e-05	0.000332	CcSEcCtD
Pazopanib—Nausea—Betamethasone—ulcerative colitis	6.07e-05	0.000332	CcSEcCtD
Pazopanib—Dizziness—Prednisone—ulcerative colitis	5.89e-05	0.000322	CcSEcCtD
Pazopanib—Vomiting—Prednisone—ulcerative colitis	5.66e-05	0.000309	CcSEcCtD
Pazopanib—Rash—Prednisone—ulcerative colitis	5.61e-05	0.000307	CcSEcCtD
Pazopanib—Dermatitis—Prednisone—ulcerative colitis	5.61e-05	0.000306	CcSEcCtD
Pazopanib—Headache—Prednisone—ulcerative colitis	5.58e-05	0.000305	CcSEcCtD
Pazopanib—Nausea—Prednisone—ulcerative colitis	5.29e-05	0.000289	CcSEcCtD
Pazopanib—FLT4—Signaling Pathways—IL6—ulcerative colitis	7.32e-06	3.77e-05	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—JAK2—ulcerative colitis	7.27e-06	3.75e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	7.26e-06	3.74e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—JAK2—ulcerative colitis	7.25e-06	3.73e-05	CbGpPWpGaD
Pazopanib—FLT1—Signaling Pathways—TGFB1—ulcerative colitis	7.25e-06	3.73e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—IFNG—ulcerative colitis	7.11e-06	3.66e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—ADRB2—ulcerative colitis	7.11e-06	3.66e-05	CbGpPWpGaD
Pazopanib—FGFR1—Innate Immune System—IL6—ulcerative colitis	7.1e-06	3.66e-05	CbGpPWpGaD
Pazopanib—LYN—Immune System—JAK2—ulcerative colitis	7.1e-06	3.65e-05	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—IL2—ulcerative colitis	7.1e-06	3.65e-05	CbGpPWpGaD
Pazopanib—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ulcerative colitis	7.09e-06	3.65e-05	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—JAK2—ulcerative colitis	7.09e-06	3.65e-05	CbGpPWpGaD
Pazopanib—FGF1—Disease—STAT3—ulcerative colitis	7.09e-06	3.65e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Innate Immune System—IL6—ulcerative colitis	7.08e-06	3.65e-05	CbGpPWpGaD
Pazopanib—LYN—Developmental Biology—IL6—ulcerative colitis	7.07e-06	3.64e-05	CbGpPWpGaD
Pazopanib—FGFR2—Immune System—NFKB1—ulcerative colitis	7.07e-06	3.64e-05	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—IL1B—ulcerative colitis	7.06e-06	3.64e-05	CbGpPWpGaD
Pazopanib—FGFR1—Disease—CD4—ulcerative colitis	7.06e-06	3.64e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—IL1B—ulcerative colitis	7.04e-06	3.63e-05	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—RELA—ulcerative colitis	7.04e-06	3.63e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Disease—CD4—ulcerative colitis	7.04e-06	3.63e-05	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—IL2—ulcerative colitis	7.04e-06	3.62e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—RELA—ulcerative colitis	7.02e-06	3.61e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—IL2—ulcerative colitis	7.02e-06	3.61e-05	CbGpPWpGaD
Pazopanib—FGFR1—Disease—PTGS2—ulcerative colitis	7.01e-06	3.61e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Disease—PTGS2—ulcerative colitis	6.99e-06	3.6e-05	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—ADCY5—ulcerative colitis	6.99e-06	3.6e-05	CbGpPWpGaD
Pazopanib—LYN—Immune System—IFNG—ulcerative colitis	6.97e-06	3.59e-05	CbGpPWpGaD
Pazopanib—KIT—Immune System—NFKB1—ulcerative colitis	6.94e-06	3.57e-05	CbGpPWpGaD
Pazopanib—LYN—Immune System—RELA—ulcerative colitis	6.87e-06	3.54e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—CD4—ulcerative colitis	6.87e-06	3.54e-05	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—RELA—ulcerative colitis	6.86e-06	3.53e-05	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—JAK2—ulcerative colitis	6.76e-06	3.48e-05	CbGpPWpGaD
Pazopanib—LYN—Immune System—CD4—ulcerative colitis	6.73e-06	3.46e-05	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—MMP9—ulcerative colitis	6.72e-06	3.46e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Disease—JAK2—ulcerative colitis	6.69e-06	3.45e-05	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—NFKB1—ulcerative colitis	6.64e-06	3.42e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—PTGS1—ulcerative colitis	6.64e-06	3.42e-05	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—CXCL8—ulcerative colitis	6.64e-06	3.42e-05	CbGpPWpGaD
Pazopanib—LCK—Immune System—CDH1—ulcerative colitis	6.64e-06	3.42e-05	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—NFKB1—ulcerative colitis	6.59e-06	3.39e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—NFKB1—ulcerative colitis	6.57e-06	3.38e-05	CbGpPWpGaD
Pazopanib—FGF1—Disease—TGFB1—ulcerative colitis	6.57e-06	3.38e-05	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—RELA—ulcerative colitis	6.55e-06	3.37e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	6.53e-06	3.36e-05	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—CXCL8—ulcerative colitis	6.47e-06	3.33e-05	CbGpPWpGaD
Pazopanib—FGFR3—Immune System—IL6—ulcerative colitis	6.45e-06	3.32e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Innate Immune System—IL6—ulcerative colitis	6.38e-06	3.29e-05	CbGpPWpGaD
Pazopanib—FGFR2—Immune System—STAT3—ulcerative colitis	6.35e-06	3.27e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—IL1B—ulcerative colitis	6.35e-06	3.27e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Disease—CD4—ulcerative colitis	6.34e-06	3.27e-05	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—IL2—ulcerative colitis	6.34e-06	3.27e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—IL2—ulcerative colitis	6.32e-06	3.26e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Disease—PTGS2—ulcerative colitis	6.3e-06	3.24e-05	CbGpPWpGaD
Pazopanib—LYN—Innate Immune System—IL6—ulcerative colitis	6.25e-06	3.22e-05	CbGpPWpGaD
Pazopanib—KIT—Immune System—STAT3—ulcerative colitis	6.24e-06	3.21e-05	CbGpPWpGaD
Pazopanib—LCK—Hemostasis—TP53—ulcerative colitis	6.21e-06	3.2e-05	CbGpPWpGaD
Pazopanib—LYN—Immune System—IL1B—ulcerative colitis	6.21e-06	3.2e-05	CbGpPWpGaD
Pazopanib—LYN—Immune System—IL2—ulcerative colitis	6.19e-06	3.19e-05	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—IL2—ulcerative colitis	6.18e-06	3.18e-05	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—CXCL8—ulcerative colitis	6.17e-06	3.18e-05	CbGpPWpGaD
Pazopanib—UGT1A1—Metabolism—PPARG—ulcerative colitis	6.14e-06	3.16e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—ADCY5—ulcerative colitis	6.03e-06	3.11e-05	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—MMP9—ulcerative colitis	6e-06	3.09e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—CALM3—ulcerative colitis	5.98e-06	3.08e-05	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—STAT3—ulcerative colitis	5.97e-06	3.07e-05	CbGpPWpGaD
Pazopanib—FLT1—Signaling Pathways—TP53—ulcerative colitis	5.97e-06	3.07e-05	CbGpPWpGaD
Pazopanib—FGFR3—Disease—IL6—ulcerative colitis	5.96e-06	3.07e-05	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—NFKB1—ulcerative colitis	5.94e-06	3.06e-05	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—STAT3—ulcerative colitis	5.92e-06	3.05e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—NFKB1—ulcerative colitis	5.92e-06	3.05e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—STAT3—ulcerative colitis	5.91e-06	3.04e-05	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—IL2—ulcerative colitis	5.9e-06	3.04e-05	CbGpPWpGaD
Pazopanib—FGFR2—Disease—STAT3—ulcerative colitis	5.86e-06	3.02e-05	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—MMP9—ulcerative colitis	5.85e-06	3.01e-05	CbGpPWpGaD
Pazopanib—LCK—Immune System—JAK2—ulcerative colitis	5.82e-06	3e-05	CbGpPWpGaD
Pazopanib—LYN—Immune System—NFKB1—ulcerative colitis	5.8e-06	2.98e-05	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—NFKB1—ulcerative colitis	5.79e-06	2.98e-05	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—PTGS1—ulcerative colitis	5.78e-06	2.98e-05	CbGpPWpGaD
Pazopanib—KIT—Disease—STAT3—ulcerative colitis	5.76e-06	2.97e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	5.71e-06	2.94e-05	CbGpPWpGaD
Pazopanib—LCK—Immune System—IFNG—ulcerative colitis	5.71e-06	2.94e-05	CbGpPWpGaD
Pazopanib—LCK—Immune System—RELA—ulcerative colitis	5.63e-06	2.9e-05	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—PPARG—ulcerative colitis	5.63e-06	2.9e-05	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—JAK2—ulcerative colitis	5.6e-06	2.88e-05	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—MMP9—ulcerative colitis	5.58e-06	2.87e-05	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—TGFB1—ulcerative colitis	5.53e-06	2.85e-05	CbGpPWpGaD
Pazopanib—UGT1A1—Metabolism—ALB—ulcerative colitis	5.52e-06	2.84e-05	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—NFKB1—ulcerative colitis	5.52e-06	2.84e-05	CbGpPWpGaD
Pazopanib—LCK—Immune System—CD4—ulcerative colitis	5.51e-06	2.84e-05	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—JAK2—ulcerative colitis	5.5e-06	2.83e-05	CbGpPWpGaD
Pazopanib—FGFR1—Disease—STAT3—ulcerative colitis	5.47e-06	2.81e-05	CbGpPWpGaD
Pazopanib—FLT1—Signaling Pathways—IL6—ulcerative colitis	5.46e-06	2.81e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Disease—STAT3—ulcerative colitis	5.45e-06	2.81e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—PTGS1—ulcerative colitis	5.45e-06	2.81e-05	CbGpPWpGaD
Pazopanib—FGFR2—Disease—TGFB1—ulcerative colitis	5.44e-06	2.8e-05	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—RELA—ulcerative colitis	5.42e-06	2.79e-05	CbGpPWpGaD
Pazopanib—ABCB1—Transmembrane transport of small molecules—ALB—ulcerative colitis	5.41e-06	2.79e-05	CbGpPWpGaD
Pazopanib—LCK—Disease—JAK2—ulcerative colitis	5.37e-06	2.77e-05	CbGpPWpGaD
Pazopanib—FGF1—Immune System—IL6—ulcerative colitis	5.36e-06	2.76e-05	CbGpPWpGaD
Pazopanib—KIT—Disease—TGFB1—ulcerative colitis	5.34e-06	2.75e-05	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—STAT3—ulcerative colitis	5.34e-06	2.75e-05	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—RELA—ulcerative colitis	5.32e-06	2.74e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—STAT3—ulcerative colitis	5.32e-06	2.74e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—JAK2—ulcerative colitis	5.22e-06	2.69e-05	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—PPARG—ulcerative colitis	5.21e-06	2.68e-05	CbGpPWpGaD
Pazopanib—LYN—Immune System—STAT3—ulcerative colitis	5.21e-06	2.68e-05	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—CALM3—ulcerative colitis	5.21e-06	2.68e-05	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—STAT3—ulcerative colitis	5.2e-06	2.68e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—JAK2—ulcerative colitis	5.2e-06	2.68e-05	CbGpPWpGaD
Pazopanib—LCK—Innate Immune System—IL6—ulcerative colitis	5.12e-06	2.64e-05	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—CXCL8—ulcerative colitis	5.11e-06	2.63e-05	CbGpPWpGaD
Pazopanib—LCK—Immune System—IL1B—ulcerative colitis	5.09e-06	2.62e-05	CbGpPWpGaD
Pazopanib—LCK—Disease—CD4—ulcerative colitis	5.09e-06	2.62e-05	CbGpPWpGaD
Pazopanib—LCK—Immune System—IL2—ulcerative colitis	5.07e-06	2.61e-05	CbGpPWpGaD
Pazopanib—FGFR1—Disease—TGFB1—ulcerative colitis	5.07e-06	2.61e-05	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—ALB—ulcerative colitis	5.06e-06	2.61e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Disease—TGFB1—ulcerative colitis	5.05e-06	2.6e-05	CbGpPWpGaD
Pazopanib—LCK—Disease—PTGS2—ulcerative colitis	5.05e-06	2.6e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	5.05e-06	2.6e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—RELA—ulcerative colitis	5.05e-06	2.6e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—RELA—ulcerative colitis	5.04e-06	2.59e-05	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—CXCL8—ulcerative colitis	5.02e-06	2.58e-05	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—STAT3—ulcerative colitis	4.96e-06	2.56e-05	CbGpPWpGaD
Pazopanib—FGF1—Disease—IL6—ulcerative colitis	4.95e-06	2.55e-05	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—TGFB1—ulcerative colitis	4.95e-06	2.55e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Disease—STAT3—ulcerative colitis	4.91e-06	2.53e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—CALM3—ulcerative colitis	4.91e-06	2.53e-05	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—IL2—ulcerative colitis	4.88e-06	2.51e-05	CbGpPWpGaD
Pazopanib—UGT1A1—Metabolism—PTGS2—ulcerative colitis	4.83e-06	2.49e-05	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—TGFB1—ulcerative colitis	4.82e-06	2.48e-05	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—IL2—ulcerative colitis	4.79e-06	2.47e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—CXCL8—ulcerative colitis	4.76e-06	2.45e-05	CbGpPWpGaD
Pazopanib—LCK—Immune System—NFKB1—ulcerative colitis	4.75e-06	2.45e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—CXCL8—ulcerative colitis	4.75e-06	2.44e-05	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—ALB—ulcerative colitis	4.69e-06	2.41e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—JAK2—ulcerative colitis	4.69e-06	2.41e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—ABCB1—ulcerative colitis	4.65e-06	2.39e-05	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—MMP9—ulcerative colitis	4.62e-06	2.38e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—PTGS1—ulcerative colitis	4.62e-06	2.38e-05	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—TGFB1—ulcerative colitis	4.6e-06	2.37e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—JAK2—ulcerative colitis	4.59e-06	2.36e-05	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—NFKB1—ulcerative colitis	4.57e-06	2.35e-05	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—TP53—ulcerative colitis	4.56e-06	2.35e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Disease—TGFB1—ulcerative colitis	4.55e-06	2.34e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—IL2—ulcerative colitis	4.55e-06	2.34e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	4.54e-06	2.34e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—RELA—ulcerative colitis	4.54e-06	2.34e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—IL2—ulcerative colitis	4.54e-06	2.34e-05	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—MMP9—ulcerative colitis	4.54e-06	2.34e-05	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—NFKB1—ulcerative colitis	4.49e-06	2.31e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—RELA—ulcerative colitis	4.44e-06	2.29e-05	CbGpPWpGaD
Pazopanib—FGFR2—Immune System—IL6—ulcerative colitis	4.44e-06	2.28e-05	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—PTGS2—ulcerative colitis	4.43e-06	2.28e-05	CbGpPWpGaD
Pazopanib—KIT—Immune System—IL6—ulcerative colitis	4.36e-06	2.24e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—ADCY5—ulcerative colitis	4.34e-06	2.23e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—MMP9—ulcerative colitis	4.31e-06	2.22e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—MMP9—ulcerative colitis	4.29e-06	2.21e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—CXCL8—ulcerative colitis	4.28e-06	2.2e-05	CbGpPWpGaD
Pazopanib—LCK—Immune System—STAT3—ulcerative colitis	4.27e-06	2.2e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—NFKB1—ulcerative colitis	4.26e-06	2.19e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—NFKB1—ulcerative colitis	4.25e-06	2.19e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—CXCL8—ulcerative colitis	4.19e-06	2.16e-05	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—IL6—ulcerative colitis	4.17e-06	2.15e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—CALM3—ulcerative colitis	4.16e-06	2.14e-05	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—IL6—ulcerative colitis	4.14e-06	2.13e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—IL6—ulcerative colitis	4.12e-06	2.12e-05	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—STAT3—ulcerative colitis	4.11e-06	2.11e-05	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—PTGS2—ulcerative colitis	4.1e-06	2.11e-05	CbGpPWpGaD
Pazopanib—FGFR2—Disease—IL6—ulcerative colitis	4.1e-06	2.11e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—IL2—ulcerative colitis	4.09e-06	2.1e-05	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—TP53—ulcerative colitis	4.07e-06	2.1e-05	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—STAT3—ulcerative colitis	4.03e-06	2.08e-05	CbGpPWpGaD
Pazopanib—KIT—Disease—IL6—ulcerative colitis	4.02e-06	2.07e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—IL2—ulcerative colitis	4e-06	2.06e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	3.97e-06	2.05e-05	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—TP53—ulcerative colitis	3.97e-06	2.04e-05	CbGpPWpGaD
Pazopanib—LCK—Disease—STAT3—ulcerative colitis	3.94e-06	2.03e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—MMP9—ulcerative colitis	3.87e-06	1.99e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—STAT3—ulcerative colitis	3.83e-06	1.97e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—NFKB1—ulcerative colitis	3.83e-06	1.97e-05	CbGpPWpGaD
Pazopanib—FGFR1—Disease—IL6—ulcerative colitis	3.82e-06	1.97e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—STAT3—ulcerative colitis	3.82e-06	1.97e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—ABCB1—ulcerative colitis	3.82e-06	1.97e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Disease—IL6—ulcerative colitis	3.81e-06	1.96e-05	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—TGFB1—ulcerative colitis	3.81e-06	1.96e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—MMP9—ulcerative colitis	3.79e-06	1.95e-05	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—TP53—ulcerative colitis	3.79e-06	1.95e-05	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—ADCY5—ulcerative colitis	3.78e-06	1.95e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—JAK2—ulcerative colitis	3.76e-06	1.94e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—NFKB1—ulcerative colitis	3.75e-06	1.93e-05	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—TGFB1—ulcerative colitis	3.74e-06	1.93e-05	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—IL6—ulcerative colitis	3.73e-06	1.92e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—IL6—ulcerative colitis	3.72e-06	1.91e-05	CbGpPWpGaD
Pazopanib—LCK—Disease—TGFB1—ulcerative colitis	3.65e-06	1.88e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—RELA—ulcerative colitis	3.64e-06	1.88e-05	CbGpPWpGaD
Pazopanib—LYN—Immune System—IL6—ulcerative colitis	3.64e-06	1.87e-05	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—IL6—ulcerative colitis	3.63e-06	1.87e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—PTGS1—ulcerative colitis	3.56e-06	1.84e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—ADCY5—ulcerative colitis	3.56e-06	1.83e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—TGFB1—ulcerative colitis	3.55e-06	1.83e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—TGFB1—ulcerative colitis	3.54e-06	1.82e-05	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—IL6—ulcerative colitis	3.47e-06	1.78e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—STAT3—ulcerative colitis	3.44e-06	1.77e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—CXCL8—ulcerative colitis	3.43e-06	1.77e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Disease—IL6—ulcerative colitis	3.43e-06	1.77e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—STAT3—ulcerative colitis	3.37e-06	1.73e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—IL2—ulcerative colitis	3.28e-06	1.69e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—PPARG—ulcerative colitis	3.23e-06	1.67e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—ABCB1—ulcerative colitis	3.23e-06	1.67e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—CALM3—ulcerative colitis	3.21e-06	1.65e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—TGFB1—ulcerative colitis	3.19e-06	1.64e-05	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—TP53—ulcerative colitis	3.13e-06	1.61e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—TGFB1—ulcerative colitis	3.12e-06	1.61e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—MMP9—ulcerative colitis	3.1e-06	1.6e-05	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—TP53—ulcerative colitis	3.08e-06	1.58e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—NFKB1—ulcerative colitis	3.07e-06	1.58e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—ADCY5—ulcerative colitis	3.02e-06	1.55e-05	CbGpPWpGaD
Pazopanib—LCK—Immune System—IL6—ulcerative colitis	2.98e-06	1.54e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—TP53—ulcerative colitis	2.92e-06	1.5e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—TP53—ulcerative colitis	2.91e-06	1.5e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—ALB—ulcerative colitis	2.91e-06	1.5e-05	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—IL6—ulcerative colitis	2.87e-06	1.48e-05	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—PPARG—ulcerative colitis	2.82e-06	1.45e-05	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—IL6—ulcerative colitis	2.82e-06	1.45e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—STAT3—ulcerative colitis	2.76e-06	1.42e-05	CbGpPWpGaD
Pazopanib—LCK—Disease—IL6—ulcerative colitis	2.75e-06	1.42e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—IL6—ulcerative colitis	2.67e-06	1.38e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—IL6—ulcerative colitis	2.67e-06	1.37e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—PPARG—ulcerative colitis	2.66e-06	1.37e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—TP53—ulcerative colitis	2.62e-06	1.35e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—TP53—ulcerative colitis	2.57e-06	1.32e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—TGFB1—ulcerative colitis	2.56e-06	1.32e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—PTGS2—ulcerative colitis	2.54e-06	1.31e-05	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—ALB—ulcerative colitis	2.53e-06	1.3e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—ABCB1—ulcerative colitis	2.5e-06	1.29e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—IL6—ulcerative colitis	2.4e-06	1.24e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—ALB—ulcerative colitis	2.39e-06	1.23e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—IL6—ulcerative colitis	2.35e-06	1.21e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—ADCY5—ulcerative colitis	2.33e-06	1.2e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—PPARG—ulcerative colitis	2.25e-06	1.16e-05	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—PTGS2—ulcerative colitis	2.22e-06	1.14e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—TP53—ulcerative colitis	2.11e-06	1.08e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—PTGS2—ulcerative colitis	2.09e-06	1.08e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—ALB—ulcerative colitis	2.02e-06	1.04e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—IL6—ulcerative colitis	1.93e-06	9.93e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—PTGS2—ulcerative colitis	1.77e-06	9.11e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—PPARG—ulcerative colitis	1.74e-06	8.94e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—ALB—ulcerative colitis	1.56e-06	8.04e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—PTGS2—ulcerative colitis	1.37e-06	7.03e-06	CbGpPWpGaD
